Avelas Biosciences announced the first patient has been dosed in Period 2 of its Phase 2 clinical trial of AVB-620 in women with primary, nonrecurrent breast cancer undergoing surgery. "We are excited to have initiated the second period of our Phase 2 study of AVB-62...
Avelas Biosciences, a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic intervention, announced the completion of Period 1 patient enrollment in its phase 2 clinical trial of AVB-620 in women with primary, nonrec...
PixelExperience / external_avb Public archive Notifications Fork 2 Star 1 Code Pull requests Actions Security Insights CommitAdd NOTICE and MODULE_LICENSE_MIT files. Browse files Bug: 69374484 Test: No code changes. All unit tests pass. Change-Id: Id4d96ed8ea38aeab91b220b61fc3007256...